comparemela.com

Latest Breaking News On - Mark bleackley - Page 6 : comparemela.com

Incannex Ltd announces final results from Phase 1 Clinical Trial assessing safety and pharmacokinetics of IHL-675A

Final results are in for a Phase 1 clinical trial to assess pharmacokinetics and the safety of Incannex Healthcare Ltd (ASX:IHL, NASDAQ:IXHL)’s.

Incannex Announces Final Results from Phase 1 Clinical

Incannex Ltd engages Catalent for development and manufacture of psilocybin for clinical trials and more

Incannex Healthcare Ltd (ASX:IHL, NASDAQ:IXHL) has engaged Catalent Pharma Solutions for the development and cGMP manufacture of its psilocybin drug.

Incannex Engages Catalent for Development and cGMP

Incannex Launches Trial of IHL-675A for Rheumatoid Arthritis

Incannex Launches Trial of IHL-675A for Rheumatoid Arthritis
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.